Azelaic Acid (Finacea Foam, BAY39-6251)

Pre-clinicalCompleted
0 watching 0 views this week💤 Quiet
20
Hype Score

Development Stage

1
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Rosacea

Conditions

Rosacea

Trial Timeline

Jul 20, 2017 → Nov 15, 2017

About Azelaic Acid (Finacea Foam, BAY39-6251)

Azelaic Acid (Finacea Foam, BAY39-6251) is a pre-clinical stage product being developed by Bayer for Rosacea. The current trial status is completed. This product is registered under clinical trial identifier NCT03193372. Target conditions include Rosacea.

Hype Score Breakdown

Clinical
5
Activity
2
Company
7
Novelty
2
Community
1

Clinical Trials (1)

NCT IDPhaseStatus
NCT03193372Pre-clinicalCompleted